Research Study Comparing a New Medicine " Fast-acting Insulin Aspart " to Another Already Available Medicine " NovoRapid " / " NovoLog " in People With Type 2 Diabetes

Conditions:   Diabetes;   Diabetes Mellitus, Type 2 Interventions:   Drug: Faster-acting insulin aspart;   Drug: Insulin aspart;   Drug: Insulin degludec;   Drug: Metformin Sponsor:   Novo Nordisk A/S Not yet recruiting - verified September 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials